"Appendiceal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the APPENDIX.
| Descriptor ID |
D001063
|
| MeSH Number(s) |
C04.588.274.476.411.184.290 C06.301.371.411.184.290 C06.405.249.411.184.290 C06.405.469.110.417.290 C06.405.469.491.184.290
|
| Concept/Terms |
Appendiceal Neoplasms- Appendiceal Neoplasms
- Appendiceal Neoplasm
- Neoplasm, Appendiceal
- Neoplasms, Appendiceal
Appendiceal Cancer- Appendiceal Cancer
- Cancer, Appendiceal
- Cancer of the Appendix
- Appendix Cancer
- Cancer, Appendix
- Cancer of Appendix
|
Below are MeSH descriptors whose meaning is more general than "Appendiceal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Appendiceal Neoplasms".
This graph shows the total number of publications written about "Appendiceal Neoplasms" by people in this website by year, and whether "Appendiceal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1999 | 3 | 0 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 1 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 0 | 3 |
| 2013 | 5 | 0 | 5 |
| 2014 | 3 | 0 | 3 |
| 2015 | 6 | 0 | 6 |
| 2016 | 3 | 0 | 3 |
| 2017 | 6 | 1 | 7 |
| 2018 | 4 | 0 | 4 |
| 2019 | 6 | 0 | 6 |
| 2020 | 5 | 2 | 7 |
| 2021 | 5 | 0 | 5 |
| 2022 | 4 | 0 | 4 |
| 2023 | 10 | 0 | 10 |
| 2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Appendiceal Neoplasms" by people in Profiles.
-
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma. Cancer Res Commun. 2024 May 29; 4(5):1363-1368.
-
Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers. JCO Precis Oncol. 2024 May; 8:e2300531.
-
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Mol Cancer Res. 2024 04 02; 22(4):329-336.
-
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open. 2024 02 05; 7(2):e240260.
-
Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma. Oncologist. 2023 Dec 11; 28(12):e1303-e1305.
-
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol. 2024 Jan; 31(1):614-621.
-
Utility of Circulating Tumor DNA in Appendiceal Tumors. J Gastrointest Surg. 2023 12; 27(12):3071-3073.
-
Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol. 2023 Dec; 30(13):8138-8143.
-
Appendiceal Neuroendocrine Neoplasms: A Comprehensive Review. J Comput Assist Tomogr. 2024 Jul-Aug 01; 48(4):545-562.
-
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer. CA Cancer J Clin. 2023 Nov-Dec; 73(6):590-596.